AZEEZ FAROOKI

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NEW YORK, NY NPI 1720165699

General Payments — all program years on this page

$111,195.18

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 252
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,024.93 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,132.001
Food and Beverage $881.6412
Education $11.291

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Ascendis Pharma Inc $2,168.302
Amgen Inc. $435.554
Corcept Therapeutics $156.673
Alexion Pharmaceuticals, Inc. $134.431
Novo Nordisk AS $69.301
BETA BIONICS, INC. $22.301
Lilly USA, LLC $21.391
Radius Health, Inc. $16.991

By program year

Program yearAmountRecords
2018 $43,638.5984
2019 $41,602.4989
2020 $4,158.4328
2021 $7,874.9819
2022 $10,064.378
2023 $831.3910
2024 $3,024.9314

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087888833 BETA BIONICS, INC. $22.30 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089937412 Radius Health, Inc. $16.99 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094016875 Alexion Pharmaceuticals, Inc. $134.43 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097482768 Novo Nordisk Inc $69.30 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111572640 Amgen Inc. $125.01 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117551535 Amgen Inc. $93.69 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117551537 Amgen Inc. $115.52 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117551539 Amgen Inc. $101.33 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117762127 Corcept Therapeutics $101.49 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117762149 Corcept Therapeutics $43.89 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117762199 Corcept Therapeutics $11.29 12/05/2024 Education Undisputed 01/23/2026 View at CMS
1133846054 Ascendis Pharma Inc $2,132.00 06/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133846943 Ascendis Pharma Inc $36.30 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136060440 Lilly USA, LLC $21.39 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.